eXmoor Pharma Plans for the Construction of New Manufacturing Facility in UK
Introduction:
eXmoor Pharma plans for the construction of new GMP cell and gene therapy manufacturing facility in UK.
Features:
The newly constructed facility, designed in-house as a flexible and scalable manufacturing hub, features integrated process development and analytical labs, four GMP clean rooms, and advanced fill/finish capabilities.
It supports the scale-up, optimisation, and production of cell therapies, RNA therapies, and viral vectors, utilising up to 2 x 200L bioreactors and multiple autologous cell therapy stations per suite. Furthermore, the facility is zero-carbon, powered entirely by solar technology and heat pumps.
The cell & gene therapy centre now provides a comprehensive range of GMP services for cell and gene therapies, including manufacturing, fill/finish, packaging, labelling, and global shipping to clinical sites.
The project signifies the completion of a two-year effort to design, construct, and launch a 65,000-square-foot, state-of-the-art facility for advanced therapies manufacturing.
Specifications:
| Name | eXmoor Pharma |
| Type | New Construction |
